ARL6IP5 and neurodegenerative disease: In neurodegenerative disease, Siddique et al. demonstrated that ARL6IP5 can reduce the burden of α-synuclein aggregates and improve cell survival in a cellular model of Parkinson’s disease by inducing autophagy through the prevention of ubiquitination and degradation of autophagy-related 12 protein [24].